Dx Revision Watch
Suzy Chapman Owner of Dx Revision Watch
- Messages
- 3,061
- Location
- UK
Also at this URL:
http://www.hhs.gov/advcomcfs/
From Tate Mitchell, via Co-Cure:
http://edocket.access.gpo.gov/2011/2011-6702.htm
http://edocket.access.gpo.gov/2011/pdf/2011-6702.pdf
May 10-11, 2011 CFSAC Meeting
[Federal Register: March 22, 2011 (Volume 76, Number 55)]
[Notices]
[Page 15982]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22mr11-88]
===========================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Chronic Fatigue Syndrome Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a
meeting. The meeting will be open to the public.
DATES: The meeting will be held on Tuesday and Wednesday, May 10 and
11, 2011. The meeting will be held from 9 a.m. until 5 p.m. on May 10,
2011, and 9 a.m. until 4:30 p.m. on May 11, 2011.
ADDRESSES: Department of Health and Human Services; Room 800, Hubert
H. Humphrey Building; 200 Independence Avenue, SW., Washington, DC
20201. For a map and directions to the Hubert H. Humphrey building,
please visit http://www.hhs.gov/about/hhhmap.html.
FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, DrPH; Executive
Secretary, Chronic Fatigue Syndrome Advisory Committee, Department of
Health and Human Services; 200 Independence Avenue, SW., Hubert
Humphrey Building, Room 712E; Washington, DC 20201. Please direct all
inquiries to cfsac@hhs.gov.
SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002.
The Committee shall advise and make recommendations to the Secretary,
through the Assistant Secretary for Health, on a broad range of topics
including (1) the current state of knowledge and research and the
relevant gaps in knowledge and research about the epidemiology,
etiologies, biomarkers and risk factors relating to CFS, and
identifying potential opportunities in these areas; (2) impact and
implications of current and proposed diagnosis and treatment methods
for CFS; (3) development and implementation of programs to inform the
public, health care professionals, and the biomedical academic and
research communities about CFS advances; and (4) partnering to improve
the quality of life of CFS patients.
The agenda for this meeting is being developed. The agenda will be
posted on the CFSAC Web site, http://www.hhs.gov/advcomcfs, when it is
finalized. The meeting will be broadcast over the Internet as a
real-time streaming video. It also will be recorded and archived for
on demand viewing through the CFSAC Web site.
Public attendance at the meeting is limited to space available.
Individuals must provide a government-issued photo ID for entry into
the building where the meeting is scheduled to be held. Those
attending the meeting will need to sign-in prior to entering the
meeting room. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the designated contact person at
cfsac@hhs.gov in advance.
Members of the public will have the opportunity to provide oral
testimony at the May 10-11, 2011, meeting if pre-registered.
Individuals who wish to address the Committee during the public
comment session must pre-register by Monday, April 18, 2011, via
e-mail to cfsac@hhs.gov. Time slots for public comment will be
available on a first-come, first-served basis and will be limited to
five minutes per speaker; no exceptions will be made. Individuals
registering for public comment should submit a copy of their oral
testimony in advance to cfsac@hhs.gov, prior to the close of business
on Monday, April 18, 2011.
If you do not submit your written testimony by the close of business
Monday, April 18, 2011, you may bring a copy to the meeting and
present it to a CFSAC Support Team staff member. Your testimony will
be included in a notebook available for viewing by the public on a
table at the back of the meeting room.
Members of the public not providing public comment at the meeting who
wish to have printed material distributed to CFSAC members for review
should submit, at a minimum, one copy of the material to the Executive
Secretary, at cfsac@hhs.gov, prior to close of business on Monday,
April 18, 2011. Submissions are limited to five typewritten pages. If
you wish to remain anonymous, please notify the CFSAC support team
upon submission of your materials to cfsac@hhs.gov.
All testimony and printed material submitted for the meeting are part
of the official meeting record and will be uploaded to the CFSAC Web
site and made available for public inspection. Testimony and materials
submitted should not include any sensitive personal information, such
as a person's social security number; date of birth; driver's license
number, State identification number or foreign country equivalent;
passport number; financial account number; or credit or debit card
number. Sensitive health information, such as medical records or other
individually identifiable health information, or any non-public
corporate or trade association information, such as trade secrets or
other proprietary information also should be excluded from any
materials submitted.
Dated: March 18, 2011.
Wanda K. Jones,
Executive Secretary, Chronic Fatigue Syndrome Advisory Committee.
[FR Doc. 2011-6702 Filed 3-21-11; 8:45 am]
BILLING CODE 4150-42-P
---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
Co-Cure Archives: http://listserv.nodak.edu/archives/co-cure.html
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------
http://www.hhs.gov/advcomcfs/
From Tate Mitchell, via Co-Cure:
http://edocket.access.gpo.gov/2011/2011-6702.htm
http://edocket.access.gpo.gov/2011/pdf/2011-6702.pdf
May 10-11, 2011 CFSAC Meeting
[Federal Register: March 22, 2011 (Volume 76, Number 55)]
[Notices]
[Page 15982]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22mr11-88]
===========================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Chronic Fatigue Syndrome Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a
meeting. The meeting will be open to the public.
DATES: The meeting will be held on Tuesday and Wednesday, May 10 and
11, 2011. The meeting will be held from 9 a.m. until 5 p.m. on May 10,
2011, and 9 a.m. until 4:30 p.m. on May 11, 2011.
ADDRESSES: Department of Health and Human Services; Room 800, Hubert
H. Humphrey Building; 200 Independence Avenue, SW., Washington, DC
20201. For a map and directions to the Hubert H. Humphrey building,
please visit http://www.hhs.gov/about/hhhmap.html.
FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, DrPH; Executive
Secretary, Chronic Fatigue Syndrome Advisory Committee, Department of
Health and Human Services; 200 Independence Avenue, SW., Hubert
Humphrey Building, Room 712E; Washington, DC 20201. Please direct all
inquiries to cfsac@hhs.gov.
SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002.
The Committee shall advise and make recommendations to the Secretary,
through the Assistant Secretary for Health, on a broad range of topics
including (1) the current state of knowledge and research and the
relevant gaps in knowledge and research about the epidemiology,
etiologies, biomarkers and risk factors relating to CFS, and
identifying potential opportunities in these areas; (2) impact and
implications of current and proposed diagnosis and treatment methods
for CFS; (3) development and implementation of programs to inform the
public, health care professionals, and the biomedical academic and
research communities about CFS advances; and (4) partnering to improve
the quality of life of CFS patients.
The agenda for this meeting is being developed. The agenda will be
posted on the CFSAC Web site, http://www.hhs.gov/advcomcfs, when it is
finalized. The meeting will be broadcast over the Internet as a
real-time streaming video. It also will be recorded and archived for
on demand viewing through the CFSAC Web site.
Public attendance at the meeting is limited to space available.
Individuals must provide a government-issued photo ID for entry into
the building where the meeting is scheduled to be held. Those
attending the meeting will need to sign-in prior to entering the
meeting room. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the designated contact person at
cfsac@hhs.gov in advance.
Members of the public will have the opportunity to provide oral
testimony at the May 10-11, 2011, meeting if pre-registered.
Individuals who wish to address the Committee during the public
comment session must pre-register by Monday, April 18, 2011, via
e-mail to cfsac@hhs.gov. Time slots for public comment will be
available on a first-come, first-served basis and will be limited to
five minutes per speaker; no exceptions will be made. Individuals
registering for public comment should submit a copy of their oral
testimony in advance to cfsac@hhs.gov, prior to the close of business
on Monday, April 18, 2011.
If you do not submit your written testimony by the close of business
Monday, April 18, 2011, you may bring a copy to the meeting and
present it to a CFSAC Support Team staff member. Your testimony will
be included in a notebook available for viewing by the public on a
table at the back of the meeting room.
Members of the public not providing public comment at the meeting who
wish to have printed material distributed to CFSAC members for review
should submit, at a minimum, one copy of the material to the Executive
Secretary, at cfsac@hhs.gov, prior to close of business on Monday,
April 18, 2011. Submissions are limited to five typewritten pages. If
you wish to remain anonymous, please notify the CFSAC support team
upon submission of your materials to cfsac@hhs.gov.
All testimony and printed material submitted for the meeting are part
of the official meeting record and will be uploaded to the CFSAC Web
site and made available for public inspection. Testimony and materials
submitted should not include any sensitive personal information, such
as a person's social security number; date of birth; driver's license
number, State identification number or foreign country equivalent;
passport number; financial account number; or credit or debit card
number. Sensitive health information, such as medical records or other
individually identifiable health information, or any non-public
corporate or trade association information, such as trade secrets or
other proprietary information also should be excluded from any
materials submitted.
Dated: March 18, 2011.
Wanda K. Jones,
Executive Secretary, Chronic Fatigue Syndrome Advisory Committee.
[FR Doc. 2011-6702 Filed 3-21-11; 8:45 am]
BILLING CODE 4150-42-P
---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
Co-Cure Archives: http://listserv.nodak.edu/archives/co-cure.html
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------